Veterinary Medicines

HuveGuard MMAT suspension for oral suspension for chickens

Authorised
  • Eimeria tenella, strain Rt 3+15, Live
  • Eimeria acervulina, strain RA 3+20, Live
  • Eimeria mitis, strain Jormit 3+9, Live
  • Eimeria maxima, strain MCK +10, Live
Download as PDF

Product identification

Medicine name:
HuveGuard MMAT suspension for oral suspension for chickens
HuveGuard MMAT
Active substance:
  • Eimeria tenella, strain Rt 3+15, Live
  • Eimeria acervulina, strain RA 3+20, Live
  • Eimeria mitis, strain Jormit 3+9, Live
  • Eimeria maxima, strain MCK +10, Live
Target species:
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Eimeria tenella, strain Rt 3+15, Live
    417.00
    oocyst(s)
    /
    0.03
    millilitre(s)
  • Eimeria acervulina, strain RA 3+20, Live
    50.00
    unit(s)
    /
    0.03
    millilitre(s)
  • Eimeria mitis, strain Jormit 3+9, Live
    278.00
    unit(s)
    /
    0.03
    millilitre(s)
  • Eimeria maxima, strain MCK +10, Live
    278.00
    unit(s)
    /
    0.03
    millilitre(s)
Pharmaceutical form:
  • Suspension for oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminum cap. Carboard box with 1 vial of 1000 doses.
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminum cap. Carboard box with 1 vial of 5000 doses.
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminum cap. Carboard box with 5 vials of 1000 doses.
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminum cap. Carboard box with 5 vials of 5000 doses.
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminum cap. Carboard box with 10 vials of 1000 doses.
  • Low density polyethylene (LDPE) vial of 30 ml with a grey butyl rubber stopper and aluminum cap. Carboard box with 10 vials of 5000 doses.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.11847.01.1
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0206/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Malta
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 23/09/2024
Download
German (PDF)
Published on: 19/12/2024
Download

2613681-paren-20200301 (1).pdf

English (PDF)
Published on: 18/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."